Ganirelix

Ganirelix (pronounced: ga-ni-rel-ix) is a medication used in fertility treatments to prevent premature ovulation. It belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) antagonists.

The name 'Ganirelix' is a coined term, with no specific etymological roots. It is a brand name for the generic drug Ganirelix acetate.

Ganirelix is used in Assisted Reproductive Technology (ART) procedures such as In Vitro Fertilization (IVF) to prevent the release of eggs from the ovaries before they are ready for retrieval. It works by blocking the action of gonadotropin-releasing hormone, a hormone that triggers ovulation.

Gonadotropin-releasing hormone (GnRH): A hormone that controls the release of other hormones (gonadotropins) involved in the menstrual cycle and ovulation.
Gonadotropin-releasing hormone (GnRH) antagonists: A class of drugs that block the action of GnRH, preventing premature ovulation.
Ovulation: The release of an egg from the ovary, usually occurring in the middle of the menstrual cycle.
In Vitro Fertilization (IVF): A type of assisted reproductive technology in which eggs are retrieved from the ovaries, fertilized in a lab, and then transferred to the uterus.
Assisted Reproductive Technology (ART): Techniques used to help individuals achieve pregnancy, including IVF and other methods.

This WikiMD article is a stub. You can help make it a full article.

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

Navigation menu